Medplus Health Services Ltd's Q4FY25 Quarterly Results
- 28 May 2025
Result Summary
- Medplus Health Services Ltd reported a 4.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 18.5%.
- Its expenses for the quarter were down by 3.2% QoQ and up 17.6% YoY.
- The net profit decreased 26.8% QoQ and increased 26.4% YoY.
- The earnings per share (EPS) of Medplus Health Services Ltd stood at 2.8 during Q4FY25.
Financial Statments for Q4FY25
(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 1500.96 | 1573.96 | 1266.68 | -4.6% | 18.5% |
Total Expenses | 1468.98 | 1517.36 | 1249.42 | -3.2% | 17.6% |
Profit Before Tax | 31.98 | 56.60 | 17.25 | -43.5% | 85.4% |
Tax | -1.58 | 10.73 | -9.30 | -114.7% | -83.0% |
Profit After Tax | 33.56 | 45.87 | 26.56 | -26.8% | 26.4% |
Earnings Per Share | 2.80 | 3.80 | 2.20 | -26.3% | 27.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Medplus Health Services Ltd is a prominent player in the healthcare industry, primarily operating in the retail pharmacy sector. It offers a wide range of pharmaceutical products and health services, catering to the needs of consumers seeking prescription drugs, over-the-counter medications, and other health-related products. The company has established a significant presence in the Indian market, characterized by its network of retail outlets that provide access to essential healthcare products. As of the latest available data, any recent major developments concerning the company are not specified.
Revenue
In the fourth quarter of the fiscal year 2025 (Q4FY25), Medplus Health Services Ltd reported a total income of ₹1500.96 crores. This marked a decrease of 4.6% compared to the previous quarter (Q3FY25), where the total income was ₹1573.96 crores. However, on a year-over-year basis, there was an increase of 18.5% from ₹1266.68 crores in Q4FY24. This growth reflects the company's ability to enhance its revenue over the past year, despite the quarterly decline.
Profitability
For Q4FY25, the company recorded a profit before tax of ₹31.98 crores, which represents a significant decrease of 43.5% from the previous quarter's ₹56.60 crores. However, compared to the same quarter the previous year (Q4FY24), there was an increase of 85.4% from ₹17.25 crores. The tax expense for Q4FY25 was -₹1.58 crores, contrasting with the previous quarter's tax of ₹10.73 crores, and showing a considerable year-over-year change from -₹9.30 crores in Q4FY24. Consequently, the profit after tax for Q4FY25 was ₹33.56 crores, down 26.8% quarter-over-quarter from ₹45.87 crores in Q3FY25, but up 26.4% year-over-year from ₹26.56 crores in Q4FY24.
Operating Metrics
The earnings per share for Q4FY25 stood at ₹2.80, showing a decrease of 26.3% from ₹3.80 in Q3FY25. Comparatively, there was an increase of 27.3% from ₹2.20 in Q4FY24. The total expenses for the quarter were ₹1468.98 crores, which is a decrease of 3.2% from ₹1517.36 crores in Q3FY25. On a year-over-year basis, total expenses increased by 17.6% from ₹1249.42 crores in Q4FY24. These figures highlight a reduction in expenses quarter-over-quarter but an overall increase year-over-year.
FAQs
Medplus Health Services Ltd announced its Q1 FY 2025-26 results on 14 August, 2025.
Medplus Health Services Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Medplus Health Services Ltd Q1 FY 2025-26 results include:
- Revenue: ₹1557.65 crore
- Net Profit: ₹42.34 crore
- EBITDA: ₹145.75 crore
- Year-over-Year Growth: 4.0%
- Quarter-over-Quarter Growth: 3.8%
Medplus Health Services Ltd reported a net profit of ₹42.34 crore in Q1 FY 2025-26, reflecting a 195.3% year-over-year growth.
Medplus Health Services Ltd posted a revenue of ₹1557.65 crore in Q1 FY 2025-26.